Lower Sixth Form pupil Elinor Davies is spending the week at Rydal Penrhos' marketing department, where she is getting a crash course in journalism from Communications Assistant Dean Jones.
For her first task she was asked to produce news reports from three major stories that hit the headlines in the last 24 hours.
Charlie Gard’s “last precious moments”
Connie Yates and Chris Gard have finally ended their five-month legal battle to secure Nucleoside Bypass Treatment (NBT) for their son.
Eleven-month-old Charlie Gard has mitochondrial depletion syndrome, a rare terminal illness causing progressive muscle weakness and brain damage. They hoped Charlie to be granted with NBT, an experimental treatment in the USA which could allow his to survive without the need for a life support machine.
In the European High Court hearing on Monday, July 24, Yates and Gard’s lawyer announced that their demands for the treatment would end after Michio Hirano, the doctor who proposed the new treatment, announced NBT would no longer save Charlie due to excessive brain damage and muscle wastage following seizures in December.
This ends a controversial legal battle with frequent disagreements between Charlie’s parents and the Great Ormond Street Hospital (GOSH). Throughout the court cases, GOSH had not supported the proposal of the new treatment and thought Yates and Gard had been “mislead” by Mr Hirano.
A statement from the hospital, said: “Devastatingly, the information obtained since 13 July gives no cause for optimism. Rather, it confirms that whilst NBT may well assist others in the future, it cannot and could not have assisted Charlie.”
Charlie’s parents, convinced he could recover if given the treatment, rejected the advice given by the hospital to switch off the life support machine and continued their legal pursuit to the European High Court of Human Rights.
GOSH have not yet given a date for the switching off of Charlie’s life support machine, but his parents have said in an emotional statement outside the High Court, that they wish to spend “the last precious moments” with their son before his death just two weeks before his first birthday.
New Problems face the NHS
A senior figure has said recently that the biggest problem facing the NHS is not a lack of funding.
Whilst Sir Mike Richards, the Chief Inspector of Hospitals in England, thought the service “no doubt” needed more money, there were bigger problems imposing on the organisation – Brexit and low recruitment.
Sir Richards has found that even in times of austerity, hospitals have been performing well, saying: “We have seen a number of hospitals actually getting better during that time.”
The issues within the organisation must therefore be attributed to other factors.
Recent data reveals 30,613 full-time vacancies advertised in March 2017, a figure that has risen by 8,000 since last year. These posts are not restricted to medical staff, many of the vacancies were found in administrative and clerical departments, showing widespread staffing problems.
Sir Richards deems Brexit as a further threat to recruitment, "If we are leaving the EU, there is a threat to that, which we need to make sure is being dealt with so that we aren't losing staff and we can then replace them,” he added.
Jimmy Choo’s Takeover
Luxury shoe and accessory makers Jimmy Choo have been bought by the American fashion house Michael Kors in a deal estimating £896m.
The company had seen slow sales in recent years, despite their floatation on the London Stock Exchange in 2014. This prompted them to search for a buyer who could help them regain former popularity, having formerly supplied shoes to the Duchess of Cambridge, Beyonce and Emma Stone.
After Jimmy Choo’s venture into the stock exchange, JAB holding (owned by the billionaire Reimann family) became the largest shareholders. They have announced recently that they fully support the takeover and look forward to the opportunity to grow the business under the management of Micheal Kors.
Mr Kors, the Chairman and chief creative officer of his namesake business, described Jimmy Choo as "a premier fashion luxury house that offers distinctive footwear, handbags and other accessories".
They hoped to expand the products available to create "a more balanced portfolio with greater product diversification" and hoped to “grow Jimmy Choo sales to one billion" before exposing themselves to the “fast-growing market” in Asia. He later added that he “admires the glamorous style and trendsetting nature of Jimmy Choo designs. We look forward to welcoming Jimmy Choo to our luxury group."